Erratum: Ischemia-reperfusion-induced unmeasured anion generation and glycocalyx shedding: Sevoflurane versus propofol anesthesia (Journal of Investigative Surgery (2012) 25:3 (162-168) DOI: 10.3109/08941939.2011.618524);Ischemiareperfusion-induced unmeasured anion generation and glycocalyx shedding: Sevoflurane versus propofol anesthesia

Journal of Investigative Surgery

Volumn 25, Issue 3, 2012, Pages 162-168

  Annecke, Thorsten ^a   Rehm, Markus ^a   Bruegger, Dirk ^a   Kubitz, Jens C ^b   Kemming, Gregor I ^a   Stoekelhuber, Mechthild ^c   Becker, Bernhard F ^a   Conzen, Peter F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acidbase equilibrium; Aortic clamp; Endothelium; Glycocalyx; Metabolic acidosis; Propofol; Sevoflurane

Indexed keywords

FENTANYL; HEPARAN SULFATE; MIDAZOLAM; PROPOFOL; SEVOFLURANE; ANESTHETIC AGENT; ETHER DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; FEMALE; GLYCOCALYX; IMMUNOHISTOLOGY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; THORACIC AORTA; ACID BASE BALANCE; ANIMAL; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; INJURY; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ACID-BASE EQUILIBRIUM; ANESTHETICS; ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOCALYX; HEPARITIN SULFATE; MALE; METHYL ETHERS; PROPOFOL; REPERFUSION INJURY; SUS SCROFA;

EID: 84861064158     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2014.943569     Document Type: Erratum

References (34)

1. Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med. 2004; 32: 1120-1124. (Pubitemid 38620978)
2. Kaplan LJ, Philbin N, Arnaud F, et al. Resuscitation from hemorrhagic shock: fluid selection and infusion strategy drives unmeasured ion genesis. J Trauma 2006; 61: 90-97. (Pubitemid 44098322)
3. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995; 82: 1026-1060.
4. Kellum JA, Kramer DJ, Pinsky MR. Strong ion gap: a methodology for exploring unexplained anions. J Crit Care 1995; 10: 51-55.
5. Collard CD,Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001; 94: 1133-1138.
6. Beresewicz A, Czarnowska E, Maczewski M. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Mol Cell Biochem. 1998; 186: 87-97. (Pubitemid 28438550)
7. Mulivor AW, Lipowsky HH. Inflammation-and ischemiainduced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004; 286: H1672-H1680. (Pubitemid 38525453)
8. Chappell D, Jacob M, Hofmann-Kiefer K, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107: 776-784. (Pubitemid 351325970)
9. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol. 2006; 176: 1-40.
10. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010; 15: 198-210.
11. Curry FR, Noll T. Spotlight on microvascular permeability. Cardiovasc Res. 2010; 15: 195-197.
12. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100: 1211-1223. (Pubitemid 38541978)
13. Chappell D, Jacob M, Becker BF, et al. Expedition glycocalyx: A newly discovered "Great Barrier Reef". Anaesthesist 2008; 57: 959-969.
14. Mulivor AW, Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol. 2002; 283: H1282-H1291.
15. Becker BF, Chappell D, Bruegger D, et al. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res. 2010; 15: 300-310.
16. Annecke T, Chappell D, Chen C, et al. Sevoflurane preserves the endothelial glycocalyx against ischaemiareperfusion injury. Br J Anaesth. 2010; 104: 414-421.
17. Annecke T, Kubitz JC, Kahr S, et al. Effects of sevoflurane and propofol on ischaemia-reperfusion injury after thoracic-aortic occlusion in pigs. Br J Anaesth. 2007; 98: 581-590. (Pubitemid 47072610)
18. Annecke T, Kubitz JC, Langer K, et al. Lung injury following thoracic aortic occlusion: comparison of sevoflurane and propofol anaesthesia. Acta Anaesthesiol Scand. 2008; 52: 977-986. (Pubitemid 351951768)
19. Institutes of Laboratory Animal Resources, Commission of Life Sciences, and National Research Council. Guide for the Use and Care of Laboratory Animals. Washington, DC: National Academy Press; 1996.
20. Lee JS, Hong JM, Kim YJ. Ischemic preconditioning to prevent lethal ischemic spinal cord injury in a swine model. J Invest Surg. 2008; 21: 209-214.
21. Kaiser GM, Frühauf NR, Zhang H, et al. Intravenous infusion anesthesia with propofol-midazolam-fentanyl for experimental surgery in Swine. J Invest Surg. 2003; 16: 353-357. (Pubitemid 38035576)
22. Figge J, Mydosh T, Fencl V. Serum proteins and acid-base equilibria: a follow up. J Lab Clin Med. 1992; 120: 713-719.
23. Durward A, Tibby SM, Skellett S, et al. The strong ion gap predicts mortality in children following cardiopulmonary bypass surgery. Pediatr Crit Care Med. 2005; 6: 281-285. (Pubitemid 40724277)
24. Kaplan LJ, Frangos S. Clinical review: Acid-base abnormalities in the intensive care unit-part II. Crit Care 2005; 9: 198-203. (Pubitemid 40425446)
25. Bruegger D, Kemming GI, Jacob M, et al. Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions. Crit Care 2007; 11: R130.
26. Forni LG, McKinnon W, Lord GA, et al. Circulating anions usually associated with theKrebs cycle in patientswith metabolic acidosis. Crit Care 2005; 5: R591-R595.
27. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29: 572-576. (Pubitemid 351544076)
28. Steppan J, Hofer S, Funke B, et al. Sepsis and abdominal surgery lead to flaking of the endothelial glycocalyx. J Surg Res. 2011; 165: 136-141.
29. Rubio-Gayosso I, Platts SH, Duling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2006; 290: H2247-H2256. (Pubitemid 43846051)
30. Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009; 104: 78-89.
31. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906. (Pubitemid 350287085)
32. Kersten JR, Schmeling TJ, Hettrick DA, et al. Mechanism of myocardial protection by isoflurane: Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 1996; 85: 794-807. (Pubitemid 26346719)
33. Chappell D, Heindl B, Jacob M, et al. Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology 2011; 115: 483-491.
34. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310. (Pubitemid 38988484)